These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7331837)

  • 21. Effects of surfactant characteristics on drug availability from suppositories.
    Realdon N; Dal Zotto M; Morpurgo M; Franceschinis E
    Pharmazie; 2008 Jun; 63(6):459-63. PubMed ID: 18604990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [In vitro and in vivo comparative studies of various barbituric acid derivatives].
    Oziebło I; Zakrzewski Z; Chałasińska B
    Acta Pol Pharm; 1986; 43(6):639-41. PubMed ID: 2883813
    [No Abstract]   [Full Text] [Related]  

  • 23. [The determination of the real dissolution rate of drug substances in melted suppository masses].
    Schöbel H; Klaus T; Raguse U; Pflegel P
    Pharmazie; 1988 Sep; 43(9):650-1. PubMed ID: 3244737
    [No Abstract]   [Full Text] [Related]  

  • 24. [Changes in the pharmaceutical and biological availability of aminophylline from suppositories containing non-ionogenic surface-active agents after a year of storage].
    Bartkowicz S; Pawlik T; Krówczyński L; Gudowska T; Gacek M
    Acta Pol Pharm; 1985; 42(2):165-71. PubMed ID: 4083053
    [No Abstract]   [Full Text] [Related]  

  • 25. [Pharmaceutical evaluation of hollow type suppository. I. Brilliant blue FCF release characteristics of oleaginous hollow type suppository].
    Watanabe Y; Matsumoto M
    Yakugaku Zasshi; 1984 May; 104(5):479-84. PubMed ID: 6491887
    [No Abstract]   [Full Text] [Related]  

  • 26. [The determination of solubility and solubility rate of drugs in melted suppository masses].
    Pflegel P; Schöbel H
    Pharmazie; 1987 Aug; 42(8):551-2. PubMed ID: 3432339
    [No Abstract]   [Full Text] [Related]  

  • 27. [Availability studies of indigenous antibiotics in suppositories].
    Verbuţă A; Cojocaru I
    Rev Med Chir Soc Med Nat Iasi; 1984; 88(3):545-50. PubMed ID: 6545455
    [No Abstract]   [Full Text] [Related]  

  • 28. Preformulation experiences and in vitro model studies with spironolactone-containing suppositories.
    Regdon G; Deák D; Regdon G; Muskó Z; Erös I
    Pharmazie; 2001 Jan; 56(1):70-3. PubMed ID: 11213791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in the plasma diazepam concentration and its anticonvulsant effect after the discharge of a diazepam suppository from the rectum in rats.
    Hidaka N; Suemaru K; Araki H
    Methods Find Exp Clin Pharmacol; 2007; 29(6):401-4. PubMed ID: 17922068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Biopharmaceutical evaluation of the rectal administration of mefenamic acid. II. Analysis of suppositories prepared on lipophilic bases].
    Kosior A
    Acta Pol Pharm; 1984; 41(5):565-9. PubMed ID: 6532137
    [No Abstract]   [Full Text] [Related]  

  • 31. [Pharmaceutical and biological availability of aminophylline in suppositories containing non-ionic surface-active agents].
    Bartkowicz S; Pawlik T; Rosiek-Pawłowska A
    Folia Med Cracov; 1979; 21(1):179-91. PubMed ID: 540870
    [No Abstract]   [Full Text] [Related]  

  • 32. [Production technology and in vitro study of rectal suppositories containing chloroquine phosphate].
    Regdon Géza JR; Schirm I; Pittmann A; Regdon G
    Acta Pharm Hung; 1995 Mar; 65(2):45-50. PubMed ID: 7793289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics and tolerance of fluconazole suppositories in healthy volunteers.
    Pfaff G; Zimmermann T; Lach P; Yeates R; Simon G; Wildfeuer A
    Arzneimittelforschung; 1993 Mar; 43(3):391-5. PubMed ID: 8489572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Biopharmaceutical testing of suppositories containing salicylic acid derivatives. II. In vivo animal experiments].
    Magyarlaki A; Minker E; Kapás M; Kedvessy G; Regdon G
    Acta Pharm Hung; 1981 Nov; 51(6):258-63. PubMed ID: 7324975
    [No Abstract]   [Full Text] [Related]  

  • 35. [The time of complete deformation of suppositories and the capacity of liberation of therapeutic substances as criteria for the evaluation of modern bases. II. In vitro studies on the liberation of substances from fatty bases].
    KROWCZYNSKI L
    Acta Pol Pharm; 1962; 19():127-42. PubMed ID: 14459871
    [No Abstract]   [Full Text] [Related]  

  • 36. [Intoxication due to replacement of the precursor methylphenobarbital by phenobarbital].
    Heeringa-Karreman M; van Munster ET
    Ned Tijdschr Geneeskd; 2006 Apr; 150(17):977-9. PubMed ID: 17225740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Biopharmaceutical evaluation of the intrarectal use of mefenamic acid. III. Effect of solubilizers on the biological availability of mefenamic acid from witepsol H15].
    Kosior A
    Acta Pol Pharm; 1986; 43(2):156-60. PubMed ID: 3776655
    [No Abstract]   [Full Text] [Related]  

  • 38. [Determination of phenobarbital in suppositories in a non-aqueous medium].
    Résibois B; Hodé C
    J Pharm Belg; 1970; 25(5):343-56. PubMed ID: 5494307
    [No Abstract]   [Full Text] [Related]  

  • 39. [Biological availability of ibuprofen in Imbun 500 suppositories].
    Hermann T; Główka FK
    Acta Pol Pharm; 1990; 47(3-4):37-40. PubMed ID: 12959240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relative bioavailability of ondansetron 8-mg oral tablets versus two extemporaneous 16-mg suppositories: formulation and gender differences.
    Jann MW; ZumBrunnen TL; Tenjarla SN; Ward ES; Weidler DJ
    Pharmacotherapy; 1998; 18(2):288-94. PubMed ID: 9545148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.